Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Crisaborole Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN120535435A reveals a safer two-phase synthesis for crisaborole intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel iodination route for Crisaborole key intermediate reduces EHS risks and improves yield. Ideal for reliable pharmaceutical intermediate supplier partnerships.